DCM
SLNO

Driehaus Capital Management’s Soleno Therapeutics SLNO Stock Holding History

Driehaus Capital Management’s Portfolio SLNO Stock Details SLNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-13,101
Closed -$886K – 477
2025
Q3 		$886K Sell
13,101
-371,172
-97% -$27.5M 0.01% 386
2025
Q2 		$32.2M Buy
384,273
+136,536
+55% +$10.2M 0.26% 126
2025
Q1 		$17.7M Buy
+247,737
New +$12.1M 0.17% 176
2024
Q3 		– Sell
-145,110
Closed -$5.92M – 444
2024
Q2 		$5.92M Buy
+145,110
New +$6.15M 0.06% 251

Other funds holding SLNO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Driehaus Capital Management's SLNO Position: Q4 2025 in Review

Driehaus Capital Management sold out of Soleno Therapeutics (SLNO) in Q4 2025, closing a stake of 13,101 shares — an estimated $886K sold.

Driehaus Capital Management first reported a position in SLNO in Q2 2024 and held it in 4 quarters. The position peaked at $32.2M in Q2 2025. 248 funds tracked by Wall St. Rank hold SLNO as of Q4 2025.

  • Driehaus Capital Management reported no remaining Soleno Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Driehaus Capital Management sold 13,101 Soleno Therapeutics shares in Q4 2025, an estimated $886K.
  • Driehaus Capital Management first reported a position in Soleno Therapeutics in Q2 2024 and held it in 4 quarters.
  • Driehaus Capital Management's Soleno Therapeutics position peaked at $32.2M in Q2 2025.
  • 248 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q4 2025.

Based on Driehaus Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.